St. Louis-based PierianDx, which provides a genomics SaaS platform for clinical labs to build personalized medicine programs, raises $27M Series B (Alaric DeArment/MedCity News)

St. Louis-based PierianDx, which provides a genomics SaaS platform for clinical labs to build personalized medicine programs, raises $27M Series B (Alaric DeArment/MedCity News)
St. Louis-based PierianDx, which provides a genomics SaaS platform for clinical labs to build personalized medicine programs, raises $27M Series B (Alaric DeArment/MedCity News)
St. Louis-based PierianDx, which provides a genomics SaaS platform for clinical labs to build personalized medicine programs, raises $27M Series B (Alaric DeArment/MedCity News)

Alaric DeArment / MedCity News:
St. Louis-based PierianDx, which provides a genomics SaaS platform for clinical labs to build personalized medicine programs, raises $27M Series B  —  The startup describes its software as providing clinical labs with more streamlined and accurate analysis, interpretation and reporting for accelerating personalized medicine programs.

from Techmeme https://ift.tt/36x7KRM

via Blogger https://ift.tt/33dLlqy
November 02, 2019 at 09:25PM
via Blogger https://ift.tt/2WEHJvi
November 02, 2019 at 10:28PM
via Blogger https://ift.tt/2NbCDDt
November 03, 2019 at 01:28AM